Sequana Medical NV (EBR: SEQUA)
Belgium
· Delayed Price · Currency is EUR 0.698
-0.026 (-3.59%)
Dec 19, 2024, 5:09 PM CET
Sequana Medical NV Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2015 |
| Revenue | 0.43 | 0.71 | 0.92 | 0.37 | 0.96 | 0.97 | Upgrade
|
| Revenue Growth (YoY) | -48.54% | -22.82% | 149.04% | -61.54% | -0.76% | -5.69% | Upgrade
|
| Cost of Revenue | 0.1 | 0.16 | 0.2 | 0.08 | 0.2 | 0.2 | Upgrade
|
| Gross Profit | 0.33 | 0.55 | 0.72 | 0.29 | 0.76 | 0.77 | Upgrade
|
| Selling, General & Admin | 21.01 | 26 | 25.49 | 20.91 | 16.71 | 13.77 | Upgrade
|
| Research & Development | 2.93 | 4.04 | 3.85 | 3.21 | 1.86 | 0.98 | Upgrade
|
| Other Operating Expenses | 0.07 | - | - | - | -0.04 | -0.02 | Upgrade
|
| Operating Expenses | 24 | 30.04 | 29.34 | 24.11 | 18.53 | 14.74 | Upgrade
|
| Operating Income | -23.67 | -29.49 | -28.62 | -23.82 | -17.77 | -13.96 | Upgrade
|
| Interest Expense | -4.39 | -1.99 | -0.88 | -0.56 | -1.08 | -0.77 | Upgrade
|
| Interest & Investment Income | 1.86 | 0 | 0 | 0 | 0.01 | 0 | Upgrade
|
| Currency Exchange Gain (Loss) | -0 | -0 | -0.29 | -0.04 | -0.11 | -0.11 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.62 | -0.62 | -0.58 | 1.19 | - | 0 | Upgrade
|
| EBT Excluding Unusual Items | -26.82 | -32.1 | -30.38 | -23.22 | -18.95 | -14.84 | Upgrade
|
| Pretax Income | -26.82 | -32.1 | -30.38 | -23.22 | -18.95 | -14.84 | Upgrade
|
| Income Tax Expense | 0.36 | 0.47 | 0.39 | 0.39 | 0.16 | 0.14 | Upgrade
|
| Net Income | -27.18 | -32.56 | -30.76 | -23.62 | -19.11 | -14.98 | Upgrade
|
| Net Income to Common | -27.18 | -32.56 | -30.76 | -23.62 | -19.11 | -14.98 | Upgrade
|
| Shares Outstanding (Basic) | 30 | 27 | 23 | 18 | 15 | 12 | Upgrade
|
| Shares Outstanding (Diluted) | 30 | 27 | 23 | 18 | 15 | 12 | Upgrade
|
| Shares Change (YoY) | 23.48% | 17.59% | 25.02% | 18.96% | 24.51% | 22.97% | Upgrade
|
| EPS (Basic) | -0.90 | -1.22 | -1.35 | -1.30 | -1.25 | -1.22 | Upgrade
|
| EPS (Diluted) | -0.90 | -1.22 | -1.35 | -1.30 | -1.25 | -1.22 | Upgrade
|
| Free Cash Flow | -25.72 | -29.77 | -28.16 | -23.94 | -17.14 | -18.59 | Upgrade
|
| Free Cash Flow Per Share | -0.85 | -1.11 | -1.24 | -1.31 | -1.12 | -1.51 | Upgrade
|
| Gross Margin | 76.53% | 76.95% | 77.83% | 79.31% | 78.99% | 79.63% | Upgrade
|
| Operating Margin | -5460.09% | -4141.05% | -3102.32% | -6428.78% | -1844.85% | -1438.60% | Upgrade
|
| Profit Margin | -6269.81% | -4572.42% | -3334.08% | -6373.84% | -1983.45% | -1543.05% | Upgrade
|
| Free Cash Flow Margin | -5931.97% | -4180.74% | -3051.80% | -6462.39% | -1779.67% | -1915.07% | Upgrade
|
| EBITDA | -23.32 | -29.14 | -28.62 | -23.68 | -17.68 | -13.95 | Upgrade
|
| D&A For EBITDA | 0.35 | 0.35 | - | 0.14 | 0.09 | 0.01 | Upgrade
|
| EBIT | -23.67 | -29.49 | -28.62 | -23.82 | -17.77 | -13.96 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.